Not applicableStudy completedNCT00081354What this trial is testingEarly Detection of Barrett's EsophagusWho this might be right forBarrett's Esophagus National Cancer Institute (NCI) 737
Not applicableLooking for participantsNCT04850729What this trial is testingRelationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer.Who this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Nanfang Hospital, Southern Medical University 169
Early research (Phase 1)Looking for participantsNCT06529822What this trial is testingPersonalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual DiseaseWho this might be right forMuscle-Invasive Bladder CarcinomaGastroesophageal AdenocarcinomaMelanoma+1 more Washington University School of Medicine 64
Not applicableStudy completedNCT00445653What this trial is testingRisk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal BleedingWho this might be right forPrecancerous Condition Massachusetts General Hospital 170
Early research (Phase 1)Study completedNCT03629756What this trial is testingEvaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesWho this might be right forNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckBreast Cancer+9 more Arcus Biosciences, Inc. 48
Large-scale testing (Phase 3)Study completedNCT02494583What this trial is testingStudy of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)Who this might be right forGastric Adenocarcinoma Merck Sharp & Dohme LLC 763
Large-scale testing (Phase 3)Looking for participantsNCT06901531What this trial is testingZolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerWho this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more Astellas Pharma Global Development, Inc.
Large-scale testing (Phase 3)Study completedNCT02314117What this trial is testingRamucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach CancerWho this might be right forMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Eli Lilly and Company 645
Not applicableStudy completedNCT01288612What this trial is testingComparative Effectiveness of Endoscopic Assessment of Gastroesophageal Reflux and Barretts EsophagusWho this might be right forBarrett's Esophagus Mayo Clinic 459
Post-approval studies (Phase 4)Not Yet RecruitingNCT07829757What this trial is testingZolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric CancerWho this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Study completedNCT01757171What this trial is testingPhase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal AdenocarcinomaDistal Esophageal Adenocarcinoma Weill Medical College of Cornell University 85
Testing effectiveness (Phase 2)Study completedNCT01443065What this trial is testingMEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal AdenocarcinomaWho this might be right forMalignant Neoplasm of EsophagusMalignant Neoplasm of Stomach UNICANCER 162
Testing effectiveness (Phase 2)Study completedNCT03929666What this trial is testingA Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerWho this might be right forHER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer Jazz Pharmaceuticals 74
Testing effectiveness (Phase 2)UnknownNCT05141747What this trial is testingMRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer.Who this might be right forLocally Advanced Gastric CancerMetastatic HER2 Positive Gastroesophageal Junction Cancer Shanghai Miracogen Inc. 60
Large-scale testing (Phase 3)Study completedNCT03081143What this trial is testingRamucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative ChemotherapyWho this might be right forAdvanced Gastric or EGJ Cancer Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 429
Testing effectiveness (Phase 2)Looking for participantsNCT07488676What this trial is testingASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsWho this might be right forGastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma Astellas Pharma Global Development, Inc. 150
Early research (Phase 1)Study completedNCT03775850What this trial is testingEDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed TumorsWho this might be right forColorectal Cancer MetastaticTriple Negative Breast CancerNon Small Cell Lung Cancer+4 more Evelo Biosciences, Inc. 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07701681What this trial is testingSacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction AdenocarcinomaWho this might be right forESCCGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more Sun Yat-sen University 75
Not applicableStudy completedNCT06499298What this trial is testingRetrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction CancerWho this might be right forEsophageal CancerGastroesophageal Junction Cancer Bristol-Myers Squibb 64
Testing effectiveness (Phase 2)Ended earlyNCT01365130What this trial is testingChemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo RegimenWho this might be right forEsophagealGastrooesophageal CancerGastric Cancer howard safran 15